TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Solid Biosciences Announces Licensing Agreement with Andelyn Biosciences for the Use of Proprietary Next-Generation Capsid AAV-SLB101

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Solid Biosciences Inc.
Solid Biosciences Announces Licensing Agreement with Andelyn Biosciences for the Use of Proprietary Next-Generation Capsid AAV-SLB101

Solid Biosciences has signed a non-exclusive worldwide license agreement with Andelyn Biosciences to provide access to its proprietary AAV-SLB101 gene therapy capsid, expanding collaborative efforts to over 30 agreements.

Insights
FFAIW   positive

The company is expanding globally, appointing a high-profile strategic advisor, and demonstrating strategic growth in electric mobility and crypto technologies


SLDB   positive

Company is expanding collaborative efforts, demonstrating successful licensing of its proprietary technology and advancing gene therapy research